Company Overview
- Headquarters
- 2100 West Loop South, Suite 900, Houston TX
- Website
- cnspharma.com
- Phone
- (800) 946-9185
- Employees
- 5
- Industry
- BioTech/Drugs
- Stock Symbol
- CNSP
Financials & Stats
Revenue
$3B
Who is CNS Pharmaceuticals
CNS Pharmaceuticals is a small biotechnology company based in Houston, Texas, with five employees. Founded with the mission of developing innovative treatments for brain and central nervous system cancers, CNS Pharmaceuticals focuses on bringing new hope to patients facing these devastating diseases. The company's lead drug candidate, Berubicin, is intended for the treatment of glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. CNS Pharmaceuticals holds exclusive rights to Berubicin worldwide and has acquired all data and expertise from past clinical trials conducted by Reata Pharmaceuticals, Inc. Preclinical studies and a completed Phase 1 trial demonstrated Berubicin's potential, showing a 44% disease control rate in patients with GBM. CNS Pharmaceuticals plans to commence a Phase 2 clinical trial of Berubicin for GBM in the United States in late 2020, with a sub-licensee partner conducting similar trials in Poland. In addition to Berubicin, CNS Pharmaceuticals is developing WP1244, a novel DNA binding agent with demonstrated significant potency against tumor cell proliferation in preclinical studies. WP1244 shows 500 times greater effectiveness than the chemotherapeutic agent daunorubicin in inhibiting tumor growth. For more information about CNS Pharmaceuticals and its groundbreaking therapies, visit www.cnspharma.com.
Company Leadership
Companies Similar to CNS Pharmaceuticals
Analyze industry trends and opportunities by examining competitors and companies comparable to CNS Pharmaceuticals, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
3M | Arvada, CO | |||
3M | 6 | Star Valley Ranch, WY | ||
3M | 4 | Ann Arbor, MI | 2006 | |
3M | 3 | San Diego, CA | ||
3M | 3 | New York, NY |